DPR & CMA Data on Disposable syringe plant (2 ml, 3 ml and 5 ml size) (body + plunger + gasket)

The disposable syringe plant project aims to manufacture 2 ml, 3 ml, and 5 ml disposable syringes, which are essential medical devices widely used in healthcare settings for drug delivery, vaccination, and sampling. The project focuses on the production of the entire syringe assembly, comprising the body, plunger, and gasket, ensuring high standards of safety and sterility. With an increasing demand for sterile medical supplies driven by rising healthcare needs and trends toward single-use products, launching this manufacturing facility presents significant business potential. The plant will leverage modern manufacturing techniques and adhere to stringent quality control regulations to meet global healthcare standards. Investment in this project not only addresses existing market demands but also positions the company as a key player in the disposable medical products sector. Given the growing population, increase in chronic diseases, and a rise in vaccination programs, the need for reliable and efficient medical delivery systems is more critical than ever. The plant will be equipped with advanced technology to enhance productivity, reduce waste, and lower operational costs while maintaining the highest standards of product quality. Additionally, strategic partnerships with healthcare institutions and suppliers can pave the way for a stable customer base and long-term growth opportunities.

• Increasing global demand for disposable medical devices.
• Rising prevalence of chronic diseases requiring regular medication delivery.
• Growing emphasis on patient safety and infection control in healthcare settings.
• Government initiatives promoting vaccination campaigns, requiring syringes.
• Expansion of healthcare infrastructure in developing regions enhancing market reach.

Total capital investment ranges from ₹2,415,000 to ₹19,850,000 depending on the scale of operation. This covers plant and machinery, civil work, pre-operative expenses, and working capital. Larger scales require proportionally higher investment but typically offer better returns.

At the larger investment scale, the expected break-even is approximately approx. 5 years at approximately 78.00% capacity utilisation. Smaller setups may reach break-even sooner due to lower fixed costs relative to the capacity.

• Polypropylene (for syringe body and plunger)
• Ethylene Vinyl Acetate (EVA) (for gasket)
• Silicone oil (for lubrication)
• Packaging materials (for sterile packaging)
• Printing ink (for labeling and branding)

• High demand for disposable syringes due to safety and convenience.
• Capability to produce multiple syringe sizes catering to diverse healthcare needs.
• Compliances with international healthcare standards ensuring product quality.